AzTrials
AzTrials

Scapholunate DissociationNCT07667114

Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis

An observational study of Scapholunate Dissociation and Scapholunate Ligament Rupture, run by Waldfriede Hospital at 1 site in Germany.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Retrospective study of patients who underwent a modified flexor carpi radialis (FCR) tenodesis for scapholunate ligament injury at Waldfriede Hospital during the period 2016-2026. Primary outcome: Functionality of the operated wrist measured using the validated DASH questionnaire. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
modified flexor carpi radialis tenodesis
Type of treatment
Surgery or procedure
How many people
100 participants
Where
1 siteGermany
Study dates
1 Jul 2026to 31 May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participation in the study is offered to all eligible patients who underwent a modified flexor carpi radialis (FCR) tenodesis for an SL ligament injury at Waldfriede Hospital between 2016 and 2026.

Who may be able to join

  • Age: ≥ 18 years
  • Capable of providing informed consent independently
  • Availability of written informed consent for the study

Who cannot join

  • Active malignant disease
  • Pregnancy at the time of the examination
  • Presence of SLAC arthritis
  • Lack of capacity to provide independent consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Markus Bock, Dr. med. contact

+493081810200

m.bock@waldfriede.de

Germany1 site, 1 recruiting
  • Waldfriede Hospital

    Berlin, State of Berlin, 14163

    Markus Bock, Dr. med., +493081810201, m.bock@waldfriede.de

    Recruiting

Other trials in Germany

About this study

Official title: Clinical Outcomes of Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis - A Retrospective Study From 2016-2026

Retrospective study of patients who underwent a modified flexor carpi radialis (FCR) tenodesis for scapholunate ligament injury at Waldfriede Hospital during the period 2016-2026.

Primary outcome: Functionality of the operated wrist measured using the validated DASH questionnaire.

Being tested
modified flexor carpi radialis tenodesis
Keywords
Scapholunate ligament, modified flexor carpi radialis (FCR) tenodesis, wrist

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • modified flexor carpi radialis tenodesisProcedure or surgery

    Flexor carpi radialis (FCR) tenodesis for the reconstruction of the dorsal scapholunate (SL) ligament and the dorsal intercarpal ligament (DICL)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) questionnaire

    DISABILITIES OF THE ARM, SHOULDER AND HAND; This questionnaire asks about symptoms as well as the ability to do certain activities regarding the upper limbs. Measure uses a 0 to 100 scoring scale, where lower scores (close to 0) represent no disability, and higher scores (close to 100) indicate maximum severity or inability to perform.

    Measured: At enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2026
  2. Study start1 Jul 2026
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07667114
Sponsor's protocol ID
BB 112/26
Status last verified
Jul 2026
First submitted
18 Jun 2026
Last updated
2 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data must remain within the clinic, and we are not permitted to share the raw data publicly or upon request with external researchers as this is the standard practice for retrospective data due to data protection/GDPR

Questions about this trial

What is this clinical trial studying?

An observational study of Scapholunate Dissociation and Scapholunate Ligament Rupture, run by Waldfriede Hospital at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Markus Bock, Dr. med. (+493081810200, m.bock@waldfriede.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) questionnaire (time frame: At enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in